KimberlyStegmaierMD
Pediatric Hematology & Oncology • Boston, MAAssistant Professor of Pediatrics, Dana-Farber Cancer Institute
Dr. Stegmaier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
44 Binney Street
Boston, MA 02115Phone+1 617-632-4985Fax+1 617-632-4850- Is this information wrong?
Education & Training
Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1999 - 2002- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1996 - 1999
Harvard Medical SchoolClass of 1996
Certifications & Licensure
MA State Medical License 1999 - 2026- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
- Super Doctor SuperDoctors.com
Clinical Trials
- Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma Start of enrollment: 2007 May 01
Publications & Presentations
PubMed
- STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.Nicole Prutsch, Shuning He, Alla Berezovskaya, Adam D Durbin, Kelsey A Maher, Jamie D Matthews, Lucy Hare, Suzanne D Turner, Lukas Kenner, Olaf Merkel, Brian J Abraham...> ;Cell Reports. Medicine. 2024 Mar 19
- The UBE2J2/UBE2K-MARCH5 ubiquitination machinery regulates apoptosis in response to venetoclax in acute myeloid leukemia.Lin, S., Schneider, C., Su, A., Alexe, G., Root, D., Stegmaier, K.> ;Leukemia. 2024 Mar 1
- 1 citationsIntegration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.Paolino, J., Dimitrov, B., Apsel Winger, B., Sandoval-Perez, A., Rangarajan, A., Ocasio-Martinez, N., Tsai, H., Li, Y., Robichaud, A., Khalid, D., Hatton, C., Gillani,...> ;Clinical Cancer Research. 2023 Nov 14
- Join now to see all
Journal Articles
- Creatine Kinase Pathway Inhibition Alters GSK3 and WNT Signaling in EVI1-Positive AMLKimberly Stegmaier, MD, Nature
- Selective Gene Dependencies in MYCN-Amplified Neuroblastoma Include the Core Transcriptional Regulatory CircuitryWilliam C Hahn, Todd R Golub, A Thomas Look, Adam D Durbin, Neekesh V Dharia, Kimberly Stegmaier, Nature
- Genome-Scale CRISPR-Cas9 Screen Identifies Druggable Dependencies in TP53 Wild-Type Ewing SarcomaLoren D. Walensky, Kimberly Stegmaier, The Journal of Experimental Medicine
- Join now to see all
Abstracts/Posters
- Core Transcriptional Regulatory Circuitries in AMLKimberly Stegmaier, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Targeting Salt-Inducible Kinase 3 As a Therapeutic Approach for Acute Myeloid LeukemiaKimberly Stegmaier, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520Kimberly Stegmaier, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Drugging the Undruggable61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- ETV6 Protein Could Be an Important Target for Ewing Sarcoma TreatmentMarch 7th, 2023
- Routing Cancer Cells to the Right Path May Boost TreatmentJuly 11th, 2022
- From Our Labs and Clinics: 10 Research Advances in 2021December 30th, 2021
- Join now to see all
Grant Support
- Targeting The ETS Transcription Factor Rearrangement EWS/FLI In Ewing'S SarcomaNational Institute On Drug Abuse2012
- Validating SYK As A Target For AML TherapyNational Cancer Institute2009–2012
- Chemical Genomics Approach To Leukemia DifferentiationNational Cancer Institute2003–2007
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
Boston Children's HospitalBoston, Massachusetts
Brigham and Women's HospitalBoston, Massachusetts
Salem HospitalSalem, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
